Author Question: What would happen if the secondary messenger cGMP was blocked in the de-etiolati (Read 540 times)

xclash

  • Hero Member
  • *****
  • Posts: 681
What would happen if the secondary messenger cGMP was blocked in the de-etiolation pathway?
A) Specific protein kinase 1 would be activated, and greening would occur.
B) Ca2+ channels would not open, and no greening would occur.
C) Ca2+ channels could open, and specific protein kinase 2 could still be produced.
D) No transcription of genes that function in de-etiolation would occur.
E) Transcription of de-etiolation genes in the nucleus would not be affected.



clippers!

  • Hero Member
  • *****
  • Posts: 828
I chose C and got the answer, hope that helps.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

A serious new warning has been established for pregnant women against taking ACE inhibitors during pregnancy. In the study, the risk of major birth defects in children whose mothers took ACE inhibitors during the first trimester was nearly three times higher than in children whose mothers didn't take ACE inhibitors. Physicians can prescribe alternative medications for pregnant women who have symptoms of high blood pressure.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library